On February 25, 2023, people with Parkinson’s, caregivers, allies, and healthcare providers from the Yale Comprehensive Parkinson's Disease Program participated in an indoor cycling event at CycleBar in West Hartford to raise awareness and funds for the Parkinson's Foundation.
- January 30, 2023
A Neuroimaging in Neurological Disorders and Diseases Symposium at Yale highlighted how imaging technology can enhance basic neuroscience research to help scientists better understand neurological diseases.
- November 29, 2022
On November 22, the American Parkinson Disease Association (APDA) Connecticut Chapter featured Veronica Santini, MD, who presented “Autonomic Dysfunction in Parkinson’s Disease” for the Association’s Summer/Fall 2022 Parkinson’s Education Series. This important webinar shed light on some of the more insidious symptoms of Parkinson’s disease (PD) that often go undetected and undertreated. The pathophysiology, signs and symptoms, and available treatments were comprehensively reviewed for the virtual audience, which included people with PD, caregivers, advocates, and healthcare professionals.
- November 01, 2022
Jesse Cedarbaum, professor adjunct of neurology and psychiatry at Yale, presented in the American Parkinson Disease Association September webinar series, “Preventing Parkinson’s Disease: The Long and Winding Road that Leads to YOUR Door." Dr. Cedarbaum gave an overview of current and future research in Parkinson's disease, as well as developments in technology designed to manage syptoms in patients.
- October 25, 2022
The Yale Movement Disorders Division joined forces with the Parkinson’s Foundation at an event entitled “Fitness Counts” on October 14, 2022. The event featured remarks by Yale's Veronica Santini, Sule Tinaz, and Christine Gummerson, as well as Beat PD Today founder Michelle Hespeler.
- May 02, 2022Source: Yale Medicine
Connecticut Magazine’s 2022 'Top Doctors' list includes more than 200 Yale Medicine physicians who were selected by their peers as the best in their fields.
- November 16, 2021
Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People With Parkinson’s Disease
Two Yale Department of Psychiatry researchers have been awarded a $2 million grant from The Michael J. Fox Foundation for Parkinson’s Research to conduct the first clinical trial of ketamine to treat depression in people with Parkinson’s disease.
- April 30, 2021Source: APDA Chapters
Topic: The Use of Brain Imaging in Parkinson’s Disease Research
- July 16, 2019
Treatments for Parkinson’s disease have most recently focused on increasing dopamine, a chemical messenger in the brain that affects reward-based behaviors and motivation, as well as movement. A new study by Yale researchers challenges long-held assumptions about dopamine’s sole role in this disorder.
- March 20, 2017
Krithi Irmady, a fourth-year neurology resident at Yale University was selected as KL2 clinical scholar at Rockefeller University and will be sponsored by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The three-year scholarship starting this summer, will allow her to serve as an Instructor in Investigative Medicine as she performs translational research in Parkinson’s Disease under the mentorship of Dr. Robert Darnell at Rockefeller University. Concurrently she will be training as a movement disorder fellow at Columbia University.